What does CUSIP 29089Q105 represent in this 13F holders report?

CUSIP 29089Q105 is the security identifier for EBS - Emergent BioSolutions Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held EBS - Emergent BioSolutions Inc. - Common Stock in Q2 2015?

181 institutional investors reported EBS - Emergent BioSolutions Inc. - Common Stock for Q2 2015. Use the holders table for investor-level position and value details.

Emergent BioSolutions Inc. - Common Stock (EBS)

CUSIP: 29089Q105

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / Common Stock
Shares outstanding: 52,021,849
Total 13F shares: 31,043,093
Share change: +647,252
Total reported value: $1,022,845,909
Price per share: $32.95
Number of holders: 181
Value change: +$25,560,178
Number of buys: 102
Number of sells: 80

Quarterly Holders Quick Answers

What is CUSIP 29089Q105?
CUSIP 29089Q105 identifies EBS - Emergent BioSolutions Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015
Previous quarter: Q1 2015

Recent filing periods for CUSIP 29089Q105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EBS - Emergent BioSolutions Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Bank of New York Mellon Corp	13F	Company	5.6%	2,928,949	$84,237,000	—	31 Mar 2015	13F
VANGUARD GROUP INC	13F	Company	4.1%	2,147,185	$61,753,000	—	31 Mar 2015	13F
Broadfin Capital, LLC	13F	Company	3.5%	1,810,519	$52,071,000	—	31 Mar 2015	13F
BlackRock Fund Advisors	13F	Company	3.3%	1,699,814	$48,887,000	—	31 Mar 2015	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	3.1%	1,595,862	$45,897,000	—	31 Mar 2015	13F
STATE STREET CORP	13F	Company	2.6%	1,371,131	$39,429,000	—	31 Mar 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.8%	949,819	$27,317,000	—	31 Mar 2015	13F
LOOMIS SAYLES & CO L P	13F	Company	1.5%	789,960	$22,719,000	—	31 Mar 2015	13F
FIDUCIARY MANAGEMENT ASSOCIATES LLC	13F	Company	1.5%	766,424	$22,043,000	—	31 Mar 2015	13F
GLENMEDE TRUST CO NA	13F	Company	1.4%	718,675	$20,668,000	—	31 Mar 2015	13F
GUGGENHEIM CAPITAL LLC	13F	Company	1.4%	715,716	$20,584,000	—	31 Mar 2015	13F
D. E. Shaw & Co., Inc.	13F	Company	1.2%	607,419	$17,469,000	—	31 Mar 2015	13F
Invesco Ltd.	13F	Company	1.1%	594,448	$17,096,000	—	31 Mar 2015	13F
PUTNAM INVESTMENTS LLC	13F	Company	1.1%	593,087	$17,057,000	—	31 Mar 2015	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.1%	586,811	$16,877,000	—	31 Mar 2015	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	1.1%	562,272	$16,171,000	—	31 Mar 2015	13F
FMR LLC	13F	Company	1.1%	546,241	$15,710,000	—	31 Mar 2015	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	1%	518,187	$14,904,000	—	31 Mar 2015	13F
Fisher Asset Management, LLC	13F	Company	0.96%	501,428	$14,421,000	—	31 Mar 2015	13F
Pine River Capital Management L.P.	13F	Company	0.78%	407,400	$11,716,000	—	31 Mar 2015	13F
NORTHERN TRUST CORP	13F	Company	0.69%	359,503	$10,339,000	—	31 Mar 2015	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.68%	352,145	$10,130,000	—	31 Mar 2015	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.64%	334,109	$9,609,000	—	31 Mar 2015	13F
Avoro Capital Advisors LLC	13F	Company	0.64%	330,635	$9,509,000	—	31 Mar 2015	13F
Numeric Investors LLC	13F	Company	0.58%	301,985	$8,685,000	—	31 Mar 2015	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.55%	285,765	$8,219,000	—	31 Mar 2015	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.55%	284,137	$8,171,000	—	31 Mar 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.47%	244,106	$7,020,000	—	31 Mar 2015	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.46%	237,290	$6,825,000	—	31 Mar 2015	13F
STRS OHIO	13F	Company	0.43%	222,900	$6,410,000	—	31 Mar 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.4%	210,500	$6,054,000	—	31 Mar 2015	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.4%	208,272	$5,990,000	—	31 Mar 2015	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.38%	195,096	$5,611,000	—	31 Mar 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.37%	194,512	$5,594,000	—	31 Mar 2015	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.35%	183,259	$5,271,000	—	31 Mar 2015	13F
AXA S.A.	13F	Company	0.35%	183,000	$5,263,000	—	31 Mar 2015	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.33%	174,059	$5,006,000	—	31 Mar 2015	13F
SEIZERT CAPITAL PARTNERS, LLC	13F	Company	0.31%	162,726	$4,680,000	—	31 Mar 2015	13F
ABERDEEN ASSET MANAGEMENT PLC/UK	13F	Company	0.31%	161,800	$4,653,000	—	31 Mar 2015	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.31%	159,785	$4,595,000	—	31 Mar 2015	13F
TFS CAPITAL LLC	13F	Company	0.29%	149,318	$4,294,000	—	31 Mar 2015	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.28%	145,942	$4,197,000	—	31 Mar 2015	13F
SEGALL BRYANT & HAMILL, LLC	13F	Company	0.28%	144,658	$4,160,000	—	31 Mar 2015	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.27%	141,490	$4,069,000	—	31 Mar 2015	13F
RUSSELL FRANK CO/	13F	Company	0.27%	139,861	$4,022,000	—	31 Mar 2015	13F
NEW AMSTERDAM PARTNERS LLC/NY	13F	Company	0.26%	136,116	$3,915,000	—	31 Mar 2015	13F
Curi Capital, LLC	13F	Company	0.26%	134,642	$3,872,000	—	31 Mar 2015	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.25%	130,623	$3,757,000	—	31 Mar 2015	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.25%	129,354	$3,720,000	—	31 Mar 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.24%	125,228	$3,601,000	—	31 Mar 2015	13F

Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2015

As of 30 Jun 2015, Emergent BioSolutions Inc. - Common Stock (EBS) was held by 181 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,043,093 shares. The largest 10 holders included Bank of New York Mellon Corp, VANGUARD GROUP INC, Broadfin Capital, LLC, BlackRock Fund Advisors, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., LOOMIS SAYLES & CO L P, FIDUCIARY MANAGEMENT ASSOCIATES LLC, and GLENMEDE TRUST CO NA. This page lists 181 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

169

Q2 2015 holders

181

Holder diff

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 Value $	Q2 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.